Sk Biopharmaceuticals competitive analysis

Loading summary...

Explore Sk Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 27, 2024Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure3
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
Jul 20, 2022Treatment Of Cataplexy1

Latest publications and patents of Sk Biopharmaceuticals New

Explore the latest publications and patents granted to Sk Biopharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sk Biopharmaceuticals

Mar 27, 2024Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence SeizureGranted And Under Opposition
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl CarbamateGranted And Under Opposition
Jul 20, 2022Treatment Of CataplexyOpposition Rejected
Oct 23, 2019Use Of Carbamate Compounds For Prevention, Alleviation Or Treatment Of Bipolar DisorderIntended To Grant

Latest PTAB cases involving Sk Biopharmaceuticals

Discover the latest PTAB cases involving Sk Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sk Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SK BIOPHARMACEUTICALS - 5 - -
DENNEMEYER & ASSOCIATES3 - - -
HAMM & WITTKOPP112 - - -
KRAUS & LEDERER PARTGMBB68 - - -